Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Rom J Ophthalmol ; 62(1): 83-87, 2018.
Article in English | MEDLINE | ID: mdl-29796439

ABSTRACT

This paper aims to discuss various therapeutical strategies (corneal cross-linking, amniotic membrane transplantation with or without autologous serum application, medical regenerative therapy) for treating ocular surface diseases according to medical indications, etiology, local and general status of the patient. Besides the evolution and treatment of the lesions induced by corneal foreign body, ocular burns, neurotrophic keratitis, pterygium removal, Mooren's ulcer, this paper also follows and evaluates the migration, stratification and development of corneal epithelium. Of course, the success of the treatment depended on the therapeutic approach, the cause of the disease, the status of the eye and the patients' compliance. All cases presented had good results, proving once again, that a well-chosen therapeutic approach ensures the improvement or cure for many ocular surface diseases nowadays. ABBREVIATIONS: BVCA = best corrected visual acuity, OCT = optical coherence tomography, CLX = corneal cross-linking.


Subject(s)
Corneal Ulcer/pathology , Eye Diseases/therapy , Amnion , Epithelium, Corneal , Humans , Visual Acuity
2.
Rom J Ophthalmol ; 60(1): 2-5, 2016.
Article in English | MEDLINE | ID: mdl-27220223

ABSTRACT

The purpose of our review was to familiarize the readers with the new concepts in ocular surface diseases and reconstruction. Limbal stem cell deficiency is characterized by the progressive invasion of conjunctival epithelial cells onto the cornea, superficial vascularisation, destruction of the corneal basement membrane, and chronic inflammatory cell infiltration. Depending on the severity of the disease and the time passed from the primary injury amniotic membrane transplantation, keratolimbal allograft and autograft are the available treatments hoping that, in the nearest future, stem cell transplantation and tissue engineering will become the usual therapeutic choices.


Subject(s)
Amnion/transplantation , Corneal Neovascularization/diagnosis , Corneal Neovascularization/surgery , Epithelium, Corneal/transplantation , Limbus Corneae/pathology , Basement Membrane/pathology , Disease Progression , Humans , Ophthalmologic Surgical Procedures , Severity of Illness Index , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL